Premium
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum
Author(s) -
Prat Jaime
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29524
Subject(s) - medicine , fallopian tube , ovary , ovarian cancer , peritoneum , fallopian tube cancer , stage (stratigraphy) , lymph , lymphadenectomy , laparoscopy , pathology , gynecology , radiology , cancer , lymph node , biology , paleontology
Ovarian, fallopian tube, and peritoneal cancers have a similar clinical presentation and are treated similarly, and current evidence supports staging all 3 cancers in a single system. The primary site (i.e. ovary, fallopian tube, or peritoneum) should be designated where possible. The histologic type should be recorded. Intraoperative rupture (“surgical spill”) is IC1; capsule ruptured before surgery or tumor on ovarian or fallopian tube surface is IC2; and positive peritoneal cytology with or without rupture is IC3. The new staging includes a revision of stage III patients; assignment to stage IIIA1 is based on spread to the retroperitoneal lymph nodes without intraperitoneal dissemination. Extension of tumor from omentum to spleen or liver (stage IIIC) should be differentiated from isolated parenchymal metastases (stage IVB). Cancer 2015;121:3435–43. © 2015 American Cancer Society .